Publication
  • ASH •
  • 8 December, 2025 •
  • •

Real-World Clinical Characteristics and Treatment Outcomes in PNH Patients Prescribed Pegcetacoplan: Insights of Complement Inhibitor-Experienced and -Naïve Patients Across Europe, the United States and Canada  

Jens Panse , Koo Wilson, Brianne Kerr, Sam Williamson, Susanna Libby, Yasmin Taylor, Peter Hillmen, David Dingli

Publication
  • ASH •
  • 7 December, 2025 •
  • •

Early Results From the Ongoing Pegcetacoplan Silo of the International Paroxysmal Nocturnal Hemoglobinuria Interest Group Registry 

Carlos de Castro, Peter Hillmen, Peter Blandino, David Araten

Publication
  • ASH •
  • 6 December, 2025 •
  • •

Optimizing PNH Treatment with the Complement Inhibitor Pegcetacoplan: A Case Report 

Edo Schaefer, Maya Siegel, Peter Blandino, Peter Hillmen

Publication
  • ASH •
  • 6 December, 2025 •
  • •

Consistent Benefits of Pegcetacoplan Treatment in PNH Patients With and Without a History of Aplastic Anemia in Real World: Analysis of the Ongoing COMPLETE Phase 4 Observational Study 

Roochi Trikha, Lenka Mastíková, Carmen Gonzalez Gonzalez, Anna-Elina Lehtinen, Elena Surova, Shammil Sadikhov, Michael O' Malley, Régis Peffault de Latour

Sign up for alerts